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Abstract 
Objectives: The purpose of this study was to evaluate the biocompatibility of MTA and the experimentally manu-
factured portland cement (EMPC). 
Study design: Twenty one Sprague Dawley (SD) rats were allocated to testing of three groups. Group I and Group 
II included ProRoot MTA and the EMPC. The materials were mixed with distilled water and placed in polyethylene 
tubes. The tubes were implanted subcutaneously in the dorsal region of the animals. Group III served as control; the 
implanted polyethylene tubes remained empty. At 7, 14, and 28 days after the implantation, the animals were sacri-
ficed and the implants were removed with the surrounding tissues. The specimens were prepared for  histological 
examination to evaluate the inflammatory response.
Results: No significant difference was found between tissue reactions against the tested materials (p>0.05). Also, 
control group showed similar results(p>0.05).
Conclusions: Results suggest that the EMPC has the potential to be used in clinical conditions in which ProRoot 
MTA is indicated. MTA and the EMPC show comparable biocompatibility when evaluated in vivo.  Although the 
results are supportive for the EMPC, more studies are required before the safe clinical use of the EMPC.
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Introduction
Biocompatibility of a material is the ability of a material 
to perform with an appropriate host response in a spe-
cific situation. This means that the tissue of the patient 
that comes into contact with the materials does not suffer 
from any toxic, irritating, inflammatory, allergic, geno-
toxic, or carcinogenic reaction (1).
Mineral trioxide aggregate (MTA) was developed as a 
retrofilling material in the 1990s. A number of biocom-
patibility studies have been conducted either in vitro or 
in vivo, and the results showed that MTA presents good 
sealing ability and tissue healing (2-9).
The chemical, physical, and biological properties of 
Portland cement (PC) were analyzed. Estrela et al. (10) 
reported that PC contains the same principal chemical 
elements as MTA, except for the bismuth oxide in MTA 
that increases the radiopacity of the material. Saidon et 
al. (11) reported that MTA and PC have similar proper-
ties but that MTA is an expensive material whereas PC 
is an economic cement.
An experimentally manufactured Portland cement 
(EMPC) was developed as an alternative to MTA by 
the Turkish Cement Manufacturers’ Association. Com-
ponents such as clay or chalk are taken directly from 
nature -including the arsenic- which appeared in PC. 
EMPC comprises pure components.
The aim of this study was to evaluate the reaction of rat 
subcutaneous connective tissue against the implantation 
of polyethylene tubes filled with MTA and EMPC.
Material and Methods
Approval for the animal use protocol presented below 
was sought and given by the Animal Ethic Committees at 
Hacettepe University (No: B.30.2.HAC.0.01.00.05/42). 
21 male Sprague-Dawley rats, each weighing 225 to 
250 g, were used in this experiment. Each animal was 
anesthetized by an intraperitoneal injection of ketamine 
hydrochloride and xylazine. Afterward, the dorsal skin 
was shaved and disinfected.
Three incisions were made in the skin using a No. 15 
scalped blade, and 2-cm pockets were created by the 
blunt dissection of the incisions. MTA was prepared 
according to the manufacturer’s instructions. EMPC 
powder was mixed with a sterile saline solution. Fresh-
ly mixed test materials were applied with an amalgam 
carrier into clean, sterile polyethylene tubes (Estern 
Medikit; Haryana, India) with a 1.3-mm inner diameter 
and 5-mm length. Each implant was carefully placed in 
a pocket, and the third incision received an empty steril-
ized tube to serve as a control. To prevent interactions of 
materials, the tubes were placed at least 2 cm apart. The 
skin was closed with 4/0 silk sutures. The evaluations 
were made 7, 14, and 28 days after surgical implanta-
tion. During each examination period, 7 animals were 
sacrificed by administration of a high dose of anesthet-
ics. The dorsal skin was shaved, and the implants were 
removed with their surrounding tissues. The samples 
were kept in a formalin solution.
After histologic processing, the tissue was serially sec-
tioned longitudinally with microtom (Leica SM-2000R, 
Leica Corp, Germany) set at 5–6 µm. The samples were 
stained with hematoxylin-eosin for the histological eval-
uation using Unna’s method for the evaluation of mast 
cells. Histological evaluations were made under a light 
microscope (Nikon Eclypse E-600, Nikon Corp, Japan) 
at 40 x, 100 x, 200 x, and 400 x magnification. The ob-
server was blinded to the procedure. Evaluation of in-
flammatory cell and mast cell infiltration was performed 
according to Salman et al (12). Statistical analysis was 
performed using the Friedman and Wilcoxon sign tests 
for intragroup comparison and Kruskal-Wallis and 
Mann-Whitney U tests for intergroup comparison.
Results
Macroscopic examination at the implant sites revealed 
that wound healing was satisfactory and without infec-
tion at all evaluation periods. The ratio of tissue reaction 
to the implanted materials is shown in Table 1.
Parameter Material N Mean count SD
7 days
Inflammation
MTA 7 2,429 0,535
EMPC 7 2,286 0,488
Control 7 2,000 0,577
Mast cell
MTA 7 2,000 0,577
EMPC 7 2,143 0,690
Control 7 1,286 0,488
14 days
Inflammation
MTA 7 1,429 0,535
EMPC 7 1,429 0,535
Control 7 1,571 0,976
Mast cell
MTA 7 1,857 0,900
EMPC 7 1,714 0,951
Control 7 1,000 0,000
28 days
Inflammation
MTA 7 1,286 0,951
EMPC 7 1,143 0,690
Control 7 1,000 0,000
Mast cell
MTA 7 1,714 0,756
EMPC 7 1,286 0,488
Control 7 0,857 0,378
Table 1. Number of implants and intensity of inflammatory  response 
at different periods of the study
- 7 Days
The means of inflammation grades for the MTA and 
EMPC groups were 2.43 ± 0.54 and 2.49 ± 0.49, respec-
tively (severe to very severe infiltration of lymphocyte 
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and plasma cells). In the control group, the mean infla-
mmation was 2.00 ± 0.58, which consisted of moderate 
infiltration of chronic inflammatory cells. There was no 
statistically significant difference between the groups 
(p<0.05), (Fig. 1).
Perivascular mast cells were observed around the end of 
the implants in all groups. The means of the number of 
mast cells for the MTA, EMPC, and control groups were 
2.00 ± 0.58 2.14 ± 0.69, and 1.29 ± 0.49, respectively. 
There was a statistically significant difference between 
the groups (p<0.05); however, no difference was found 
between MTA and PCRA (p>0.05).
- 14 Days
The means of inflammation grades for both MTA and 
EMPC groups were 1.43 ± 0.54, which consisted of mo-
derate infiltration of predominantly chronic inflamma-
tory cells. In the control group, the mean inflammation 
was 1.58 ± 0.98, which consisted of moderate infiltration 
of chronic inflammatory cells. There was no statistically 
significant difference between the groups (p<0.05), (Fig. 
2).
The means of the number of mast cells for the MTA, 
EMPC, and control groups were 1.86 ± 0.90, 1.71 ± 0.95, 
and 1.00 ± 0.00, respectively. There was no statistically 
significant difference between the groups (p<0.05).
- 28 Days
The means of inflammation grades for the MTA and 
EMPC groups were 1.29 ± 0.95 and 1.14 ± 0.69, in-
cluding mild infiltration of inflammatory cells. In the 
control group, the mean inflammation was 1.00 ± 0.00. 
There was no statistically significant difference between 
the groups (p<0.05), (Fig. 3).
The means of the number of mast cells for the MTA, 
EMPC, and control groups were 1.71 ± 0.76, 1.29 ± 0.49, 
and 0.86 ± 0.38, respectively. There was no statistically 
significant difference between the groups (p<0.05).
Mild inflammatory cell infiltration around the implants 
was observed in all groups after 7 and 14 days. This in-
flammatory infiltration comprised mostly plasma cells 
and lymphocytes. Numerous neutrophils were seen in 
the 7-day groups while the 14-day groups showed a few 
neutrophils. At day 28, all groups had fewer inflamma-
Fig. 1. A) EMPC, 7th day (H&E, x100); B) MTA, 7th day (H&E, x100); C) Control, 7th day (H&E, x100).
Fig. 2. A) EMPC, 14th day (H&E, x200), B) MTA, 14th day (H&E, x100), 3c: Control, 14th day (H&E, x100).
Fig. 3. A)EMPC, 28th day (H&E, x100), B) MTA, 28th day (H&E, x100), C) Control, 28th day (H&E, x200).
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strated that Portland cement shows a statistically signifi-
cant decrease in inflammation grades at 7-, 15-, 30-, and 
60-day intervals. Menezes et al. (8) indicated that MTA 
and Portland cement show a decrease in inflammation 
severity in the subcutaneous connective tissue in rats at 
7-, 30-, and 60-day intervals.
Tissue reactions associated with ProRoot and EMPC im-
plants were comparable. After 28-day intervals, inflam-
matory processes associated with most of the implants 
decreased significantly, suggesting that both materials 
are equally biocompatible. Our results were in accor-
dance with previously published studies in which the tis-
sue reaction to PC was compared with the tissue reaction 
to ProRoot MTA (11,25,26,27).
Mast cells are key elements in the innate immune sys-
tem and have been termed the antennae of the immune 
response for their ability to detect changes in their en-
vironment and communicate these to other cells in the 
vicinity. Mast cells are located throughout the body in 
close proximity to epithelial surfaces, near blood ves-
sels, nerves, and glands, placing them at strategic loca-
tions to detect invading pathogens. Mast cells express 
a number of receptors that allow them to recognize di-
verse stimuli (28). In our study, we observed that EMPC 
stimulated mast cells much like MTA. Both materials 
demonstrated a similar effect on inflammatory response 
and wound healing.
The results of the present study demonstrate that all the 
implanted materials are well tolerated by tissues and 
have acceptable biocompatibility. However, before ex-
trapolation of these results to an applicable human clini-
cal situation, further studies are necessary to evaluate 
the suitability of the experimentally-manufactured Port-
land cement. In conclusion, EMPC is as biocompatible 
as MTA, with no significant differences.
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